Market overview
The global pharmaceutical glass market is worth USD 19.4 bn in 2026 and is forecast to reach USD 38.8 bn by 2036, growing at a 7.2% CAGR. United States is the largest country market and Vials is the largest by product segment.
| Scope | Glass vials, ampoules, cartridges, syringe barrels and bottles made from borosilicate and soda-lime glass for packing injectables, vaccines and liquid medicines. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 18.0 bn |
| Value 2026 | USD 19.4 bn |
| Value 2036 | USD 38.8 bn |
| CAGR 2026-2036 | 7.2% |
| Volume 2026 | 63,861 million pieces |
| Volume 2036 | 115,870 million pieces |
| Average price 2026 | USD 0.30 per piece |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Pharmaceutical Glass market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 19.4 bn |
| 2027 | USD 20.7 bn |
| 2028 | USD 22.2 bn |
| 2029 | USD 23.8 bn |
| 2030 | USD 25.6 bn |
| 2031 | USD 27.4 bn |
| 2032 | USD 29.4 bn |
| 2033 | USD 31.5 bn |
| 2034 | USD 33.7 bn |
| 2035 | USD 36.2 bn |
| 2036 | USD 38.8 bn |
Pharmaceutical Glass market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Vials | 36.0% | 37.2% | USD 7.0 bn | 7.5% |
| Ampoules | 10.0% | 7.1% | USD 1.9 bn | 3.5% |
| Cartridges and syringes | 26.0% | 32.3% | USD 5.0 bn | 9.5% |
| Bottles and jars | 20.0% | 16.3% | USD 3.9 bn | 5.0% |
| Other | 8.0% | 7.2% | USD 1.5 bn | 6.0% |
By glass type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Borosilicate Type I | 62.0% | 65.9% | USD 12.0 bn | 7.9% |
| Treated soda-lime Type II | 18.0% | 16.9% | USD 3.5 bn | 6.6% |
| Soda-lime Type III | 20.0% | 17.1% | USD 3.9 bn | 5.6% |
By drug type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Generic injectables | 32.0% | 27.0% | USD 6.2 bn | 5.4% |
| Biologics | 24.0% | 29.0% | USD 4.6 bn | 9.2% |
| Vaccines | 20.0% | 23.0% | USD 3.9 bn | 8.7% |
| Oral and topical liquids | 14.0% | 12.0% | USD 2.7 bn | 5.6% |
| Diagnostics and others | 10.0% | 9.0% | USD 1.9 bn | 6.1% |
By surface treatment
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Uncoated | 56.0% | 50.0% | USD 10.8 bn | 6.0% |
| Silicone treated | 20.0% | 18.0% | USD 3.9 bn | 6.1% |
| Barrier coated | 16.0% | 22.0% | USD 3.1 bn | 10.7% |
| Ammonium sulfate treated | 8.0% | 10.0% | USD 1.5 bn | 9.6% |
By buyer
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Branded pharma | 36.0% | 34.0% | USD 7.0 bn | 6.6% |
| Generic makers | 34.0% | 29.0% | USD 6.6 bn | 5.5% |
| Fill-finish contractors | 22.0% | 27.0% | USD 4.3 bn | 9.4% |
| Biotech and diagnostics | 8.0% | 10.0% | USD 1.5 bn | 9.6% |
Top 25 countries for pharmaceutical glass by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 73.0% of 2026 revenue and the 25 countries below together hold 91.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 4.5 bn | 23.0% | USD 8.3 bn | 6.4% |
| 2 | China | USD 2.9 bn | 15.0% | USD 6.8 bn | 8.9% |
| 3 | India | USD 1.5 bn | 8.0% | USD 4.0 bn | 9.9% |
| 4 | Germany | USD 1.2 bn | 6.0% | USD 2.0 bn | 5.5% |
| 5 | Japan | USD 968 mn | 5.0% | USD 1.6 bn | 4.8% |
| 6 | Italy | USD 774 mn | 4.0% | USD 1.4 bn | 5.8% |
| 7 | France | USD 677 mn | 3.5% | USD 1.2 bn | 5.9% |
| 8 | Brazil | USD 580 mn | 3.0% | USD 1.2 bn | 7.5% |
| 9 | United Kingdom | USD 580 mn | 3.0% | USD 1.0 bn | 6.1% |
| 10 | South Korea | USD 484 mn | 2.5% | USD 970 mn | 7.2% |
| 11 | Mexico | USD 468 mn | 2.4% | USD 939 mn | 7.2% |
| 12 | Switzerland | USD 468 mn | 2.4% | USD 939 mn | 7.2% |
| 13 | Spain | USD 410 mn | 2.1% | USD 725 mn | 5.9% |
| 14 | Canada | USD 331 mn | 1.7% | USD 586 mn | 5.9% |
| 15 | Russia | USD 281 mn | 1.4% | USD 496 mn | 5.9% |
| 16 | Poland | USD 244 mn | 1.3% | USD 613 mn | 9.7% |
| 17 | Indonesia | USD 219 mn | 1.1% | USD 547 mn | 9.6% |
| 18 | Turkey | USD 197 mn | 1.0% | USD 496 mn | 9.7% |
| 19 | Netherlands | USD 180 mn | 0.9% | USD 318 mn | 5.9% |
| 20 | Australia | USD 166 mn | 0.9% | USD 295 mn | 5.9% |
| 21 | Belgium | USD 155 mn | 0.8% | USD 275 mn | 5.9% |
| 22 | Thailand | USD 145 mn | 0.8% | USD 365 mn | 9.7% |
| 23 | Saudi Arabia | USD 137 mn | 0.7% | USD 345 mn | 9.7% |
| 24 | Argentina | USD 130 mn | 0.7% | USD 326 mn | 9.7% |
| 25 | Taiwan | USD 124 mn | 0.6% | USD 217 mn | 5.8% |
| Rest of world | USD 1.6 bn | 8.1% | USD 2.9 bn | 6.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- SCHOTT Pharma
- Gerresheimer
- Corning
- Stevanato Group
- Nipro
Group 2: Regional and specialist players
- SGD Pharma
- Bormioli Pharma
- Piramal Glass
- Shandong Pharmaceutical Glass
- DWK Life Sciences
- Sisecam
- Linuo Group
- Cangzhou Four-Star Glass
Group 3: Emerging and niche players
- Borosil
- Neubor Glass
- Kapoor Glass
- Haldyn Glass
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the pharmaceutical glass market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.2% is calculated from the resulting values.
The market is divided by product, by glass type, by drug type, by surface treatment, by buyer. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the pharmaceutical glass market?
The global pharmaceutical glass market is estimated at USD 18.0 bn in 2025 and USD 19.4 bn in 2026.
How fast will the pharmaceutical glass market grow?
It is forecast to reach USD 38.8 bn by 2036, a compound annual growth rate of 7.2% from 2026, an increase of USD 19.4 bn.
Which country is the largest market for pharmaceutical glass?
United States is the largest market by revenue at USD 4.5 bn in 2026, 23.0% of the global total. The three largest countries together hold 46.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.9% a year from 2026 to 2036.
Which pharmaceutical glass segment is largest?
In the by product split, Vials is the largest segment with 36.0% of 2026 revenue.
Who are the leading pharmaceutical glass companies?
Global leaders include SCHOTT Pharma, Gerresheimer, Corning, Stevanato Group.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Injectable Drug DeliveryUSD 19.6 bn · 9.0% CAGR
- Nasal Drug DeliveryUSD 19.1 bn · 6.2% CAGR
- Medical BillingUSD 20.0 bn · 11.0% CAGR
- NanomedicineUSD 20.1 bn · 9.0% CAGR
- Metered Dose InhalerUSD 17.9 bn · 5.0% CAGR
- Surgical RoboticsUSD 17.7 bn · 14.0% CAGR
- SyringeUSD 21.2 bn · 6.5% CAGR
- Fill FinishUSD 17.6 bn · 9.0% CAGR